Technical Analysis for AMRX - Amneal Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 2.74 -1.44% -0.04
AMRX closed up 0.36 percent on Wednesday, August 21, 2019, on 72 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical AMRX trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup -1.44%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.44%
Inside Day Range Contraction -1.44%
Wide Bands Range Expansion -1.44%
1,2,3 Retracement Bearish Bearish Swing Setup -1.08%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.08%
Wide Bands Range Expansion -1.08%
Oversold Stochastic Weakness -1.08%
Wide Bands Range Expansion -4.20%
Oversold Stochastic Weakness -4.20%

Older signals for AMRX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Amneal Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. It operates in two segments, which include Impax Generics and Impax Specialty Pharma. The Impax Generics is focused on the development, manufacture, sale and distribution of the Company's generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their drug names. The Impax Specialty Pharma is engaged in the promotion, sale and distribution of several branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson's disease (PD), post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.
Health Pharmaceutical Pharmaceutical Industry Drugs Pharmaceuticals Policy Health Sciences Parkinson's Disease Treatment Of Parkinson's Disease Generic Drug Treatment Of Migraine Generic Products L Dopa Pharmaceutical Product
Is AMRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.35
52 Week Low 2.38
Average Volume 2,168,533
200-Day Moving Average 11.337
50-Day Moving Average 4.6506
20-Day Moving Average 3.0655
10-Day Moving Average 2.739
Average True Range 0.2879
ADX 45.42
+DI 17.7072
-DI 32.536
Chandelier Exit (Long, 3 ATRs ) 3.0263
Chandelier Exit (Short, 3 ATRs ) 3.2437
Upper Bollinger Band 3.8924
Lower Bollinger Band 2.2386
Percent B (%b) 0.33
BandWidth 53.948785
MACD Line -0.5604
MACD Signal Line -0.6661
MACD Histogram 0.1056
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.07
Resistance 3 (R3) 3.06 2.96 3.02
Resistance 2 (R2) 2.96 2.89 2.96 3.00
Resistance 1 (R1) 2.87 2.84 2.82 2.88 2.99
Pivot Point 2.77 2.77 2.75 2.77 2.77
Support 1 (S1) 2.68 2.70 2.63 2.69 2.57
Support 2 (S2) 2.58 2.65 2.58 2.56
Support 3 (S3) 2.49 2.58 2.54
Support 4 (S4) 2.50